A detailed history of Prostatis Group LLC transactions in First Tr Exc Tr Fd Iv Cboe Vst stock. As of the latest transaction made, Prostatis Group LLC holds 148,867 shares of RDVI stock, worth $0. This represents 0.96% of its overall portfolio holdings.

Number of Shares
148,867
Previous 161,224 7.66%
Holding current value
$0
Previous $3.98 Billion 3.4%
% of portfolio
0.96%
Previous 1.14%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
N/A
-12,357 Reduced 7.66%
148,867 $3.85 Billion
Q2 2025

Jul 25, 2025

BUY
N/A
16,325 Added 11.27%
161,224 $3.98 Billion
Q1 2025

May 16, 2025

BUY
N/A
5,453 Added 3.91%
144,899 $3.44 Billion
Q4 2024

Mar 21, 2025

BUY
N/A
18,248 Added 15.06%
139,446 $3.38 Billion
Q3 2024

Mar 21, 2025

BUY
N/A
13,779 Added 12.83%
121,198 $2.99 Billion
Q2 2024

Mar 21, 2025

BUY
N/A
19,218 Added 21.79%
107,419 $2.51 Billion
Q1 2024

Mar 21, 2025

BUY
N/A
88,201 New
88,201 $2.16 Billion

Others Institutions Holding RDVI

About FIRST TR EXC-TR FD IV CBOE VST


  • Ticker RDVI
More about RDVI
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.